Komori
Seed (7743) · InitiativeFirst stated

Regulatory Approvals in China, Southeast Asia and Europe

First written in FY2016. . Latest entry: FY2016.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Strengthening overseas and global sales and business developmentA theme 265 companies write about · 1 as a headwind · 290 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 183 companies compared. The sentences above are computed from all 183.Comparing 200 of the theme's 293 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2016First statedAnnual report

    「We are pursuing regulatory approvals in each country to expand our contact lenses and lens-care products into China, Southeast Asia and Europe.」

    We are pursuing regulatory approvals in each country as a means of expanding overseas.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Seed yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Regulatory Approvals in China, Southeast Asia and Europe | SEED CO.,LTD. (7743) | Komori